awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33224563-BEA2FDA2-9E92-4DF5-B434-FDF6F91EB950
Q33224563-BEA2FDA2-9E92-4DF5-B434-FDF6F91EB950
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33224563-BEA2FDA2-9E92-4DF5-B434-FDF6F91EB950
Proton pump inhibitor formulary considerations in the acutely ill. Part 2: Clinical efficacy, safety, and economics.
P2860
Q33224563-BEA2FDA2-9E92-4DF5-B434-FDF6F91EB950
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33224563-BEA2FDA2-9E92-4DF5-B434-FDF6F91EB950
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
986b268090898dd6b523454ec7f34f861c2f2ef2
P2860
Replacement of oral proton pump inhibitors with intravenous pantoprazole to effectively control gastric acid hypersecretion in patients with Zollinger-Ellison syndrome.